Morningside Technology Ventures

Total investments

87

Average round size

35M

Portfolio companies

76

Rounds per year

2.29

Lead investments

28

Follow on index

0.13

Exits

6

Areas of investment
BiotechnologySoftwareHealth CareEducationManufacturingMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

The main office of represented VC is situated in the Shanghai. The fund was located in Asia if to be more exact in China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Morningside Technology Ventures, startups are often financed by University Ventures, Morningside Group, Top Line Growth Capital. The meaningful sponsors for the fund in investment in the same round are University Ventures, Tamarisc Ventures, Topline Capital. In the next rounds fund is usually obtained by University Ventures, Tudor Growth Equity, The Exxel Group.

Among the most popular portfolio startups of the fund, we may highlight Rockley Photonics, Jitjatjo, Ignition Design Labs. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Education, Internet. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Morningside Technology Ventures works on 19 percentage points less the average amount of lead investments. The top activity for fund was in 2019.

Show more

Investments analytics

Analytics

Total investments
87
Lead investments
28
Exits
6
Rounds per year
2.29
Follow on index
0.13
Investments by industry
  • Biotechnology (40)
  • Health Care (25)
  • Medical (15)
  • Pharmaceutical (15)
  • Therapeutics (13)
  • Show 92 more
Investments by region
  • United States (61)
  • China (10)
  • United Kingdom (9)
  • Netherlands (1)
  • France (2)
  • Show 4 more
Peak activity year
2021
Number of Unicorns
3
Number of Decacorns
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
113M
Group Appearance index
0.60
Avg. company exit year
10
Avg. multiplicator
5.78
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Phage Pharm 01 Mar 2023 Biotechnology, Pharmaceutical Early Stage Venture 13M Shandong, Qingdao Shi, China
Xencore Network 11 May 2024 Late Stage Venture Beijing, Haidian, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.